These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16565552)

  • 1. The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan.
    Oda E; Oohara K; Abe A; Veeraveedu PT; Watanabe K; Kato K; Aizawa Y
    Circ J; 2006 Apr; 70(4):384-8. PubMed ID: 16565552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.
    Han TS; Sattar N; Williams K; Gonzalez-Villalpando C; Lean ME; Haffner SM
    Diabetes Care; 2002 Nov; 25(11):2016-21. PubMed ID: 12401749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prevalence of metabolic syndrome in middle-aged in Kaunas population].
    Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R
    Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
    Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
    Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tentative cut point of high-sensitivity C-reactive protein for a component of metabolic syndrome in Japanese.
    Oda E; Kawai R
    Circ J; 2009 Apr; 73(4):755-9. PubMed ID: 19225207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
    Srećković B; Soldatovic I; Colak E; Mrdovic I; Sumarac-Dumanovic M; Janeski H; Janeski N; Gacic J; Dimitrijevic-Sreckovic V
    Drug Metab Pers Ther; 2018 Jun; 33(2):99-103. PubMed ID: 29624500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity C-reactive protein in airline pilots with metabolic syndrome.
    Alonso-Rodríguez C; Medina-Font J
    Aviat Space Environ Med; 2012 May; 83(5):504-8. PubMed ID: 22606867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh Study.
    Nakanishi N; Shiraishi T; Wada M
    Circ J; 2005 Apr; 69(4):386-91. PubMed ID: 15791030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome.
    Cho DH; Joo HJ; Kim MN; Lim DS; Shim WJ; Park SM
    Cardiovasc Diabetol; 2018 Jun; 17(1):95. PubMed ID: 29960588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein is elevated in obese patients with the metabolic syndrome.
    Florez H; Castillo-Florez S; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Lee D; Goldberg R
    Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease.
    Matsuo Y; Hashizume T; Shioji S; Akasaka T
    Circ J; 2008 Dec; 72(12):2046-50. PubMed ID: 18946171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].
    Yang SP; Gong CX; Cao BY; Yan C
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):933-6. PubMed ID: 17254464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.
    Mirhafez SR; Ebrahimi M; Saberi Karimian M; Avan A; Tayefi M; Heidari-Bakavoli A; Parizadeh MR; Moohebati M; Azarpazhooh MR; Esmaily H; Nematy M; Safarian M; Ferns GA; Ghayour-Mobarhan M
    Eur J Clin Nutr; 2016 Nov; 70(11):1298-1304. PubMed ID: 27460263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study.
    Nakanishi N; Shiraishi T; Wada M
    Intern Med; 2005 Jun; 44(6):542-7. PubMed ID: 16020877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of C reactive protein levels with metabolic syndrome in adults: a population-based study].
    Bustos P; Rosas B; Román P; Villagrán J; Amigo H
    Rev Med Chil; 2016 Oct; 144(10):1239-1246. PubMed ID: 28074977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Dietary Inflammatory Index, C-Reactive Protein and Metabolic Syndrome: A Cross-Sectional Study.
    Ren Z; Zhao A; Wang Y; Meng L; Szeto IM; Li T; Gong H; Tian Z; Zhang Y; Wang P
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29954070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study.
    Pérez-Tasigchana RF; León-Muñoz LM; Lopez-Garcia E; Gutierrez-Fisac JL; Laclaustra M; Rodríguez-Artalejo F; Guallar-Castillón P
    Age Ageing; 2017 Sep; 46(5):807-812. PubMed ID: 28338890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal cut-off value for homeostasis model assessment (HOMA) index of insulin-resistance in a population of patients admitted electively in a Portuguese cardiology ward.
    Timóteo AT; Miranda F; Carmo MM; Ferreira RC
    Acta Med Port; 2014; 27(4):473-9. PubMed ID: 25203956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.